$2.60 -0.11 (-4.06%)
11/20/2009 4:00 PM

EXACT Sciences Corp (EXAS)

CAPS Rating: 5 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Featured Broker Partners